“…it also appears that more might be done to translate what is shown into practice on an individualized basis in the context of post fracture preventive efforts in light of the immense importance of reducing the prevalence of second or third hip fractures, 46 and mortality rates 47 along with higher rates of disability than those cases experiencing single hip fractures, which alone is substantive. 48 Needed in terms of research however, are both consortia as well as funders willing to support the desired magnitude and scope of effort required to ensure success, including the use of some agreed upon standard procedures, sampling strategies, and outcome measures, plus long term follow up studies of well defined samples of hip fracture subgroups of various ages, and of various degrees of health, located in diverse geographic, institutional, community and cultural venues and locations. Until then, and in light of the growing number of older adults worldwide, and the fact that many already suffer from multiple health issues and frailty as well as obesity and bone fragility, hip fracture prevalence rates are yet more likely to rise, rather than fall over time, even though pharmacologic strategies have yielded some protective benefits for some time.…”